NSE filing, NSE: CMPDI. Summary written from the filing by ALFA Finder's alert engine.
Central Mine Planning & Design Institute Ltd: key numbers
- Share price
- ₹186.80
- Market cap
- ₹13,338 Cr
- Revenue (annual)
- ₹2,317 Cr
- Net profit (annual)
- ₹613.2 Cr
- P/E (TTM)
- 19.9×Sector 36.4×
- Promoter holding
- 85.00%+0.00% QoQ
- FII holding
- 0.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Central Mine Planning & Design Institute Ltd
All →Central Mine Planning & Design Institute Investor Presentation: Key Takeaways
H1 FY27 revenue ₹1,074.68 Cr (+11.8%), PAT ₹311.11 Cr (+23.1%), EBITDA margin 40.54%. Q2 revenue +8%, PAT +10%. Growth via MoUs and exploration mandates.
Central Mine Planning & Design Institute Dividend
CMPDI declared a second interim dividend of Rs. 1.05 per share for FY 2026-27. Record date is 29 October 2026 with payment by 22 November 2026.
Central Mine Planning & Design Institute Business Update
CMPDI reported drilling achieved 102% of FY26-27 target up to September 2026. Seismic survey hit 116% of its annual Line-Km target.
Central Mine Planning & Design Institute Q2 FY27 Results: Net Profit ₹194.8 Cr, Up 10.0% YoY
Central Mine Planning & Design Institute Ltd reported revenue from operations of ₹593.3 Cr (+7.5% YoY) and net profit of ₹194.8 Cr (+10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹194.8 Cr · +10.0% YoY
Central Mine Planning & Design Institute Management Change
Central Mine Planning & Design Institute Limited appointed Rajesh Kumar Gupta as Head of Exploration, replacing S K Gupta, effective October 14, 2026.
Central Mine Planning & Design Institute Board Meeting Outcome
CMPDI's board approved draft MoUs with OIL India and CSIR-CIMFR for technical collaboration. The board also reconstituted committees and fixed auditor remuneration.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.